Table 1.
Baseline characteristics of the study population according to the presence of COVID-19 disease after kidney transplantation
| Demographic Characteristics | All Patients, n=1216 | COVID-19–Positive Patients, n=66 | COVID-19–Negative Patients, n=1150 | P Valuea |
|---|---|---|---|---|
| Age, yr | 54.1±13.4 | 56.4±12.5 | 54.0±13.4 | 0.14 |
| Men, no. (%) | 777 (64) | 37 (56) | 740 (64) | 0.17 |
| Non-White, no. (%) | 222 (24) | 24 (36) | 198 (17) | <0.001 |
| Blood group, no. (%) | 0.90 | |||
| A | 463 (38) | 23 (35) | 440 (38) | |
| B | 194 (16) | 12 (18) | 182 (16) | |
| O | 489 (40) | 28 (42) | 461 (40) | |
| AB | 70 (6) | 3 (5) | 67 (6) | |
| Cause of ESKD, no. (%) | 0.13 | |||
| Glomerulopathies | 254/1206 (21) | 7/66 (11) | 247/1140 (22) | |
| Diabetes | 195/1206 (16) | 12/66 (18) | 183/1140 (16) | |
| Vascular | 209/1206 (17) | 16/66 (24) | 196/1140 (17) | |
| Other | 548/1206 (46) | 31/66 (47) | 514/1140 (45) | |
| Deceased donor, no. (%) | 1053 (87) | 64 (97) | 989 (86) | <0.001 |
| Prior kidney transplant, no. (%) | 132 (11) | 8 (12) | 124 (11) | 0.69 |
| Time on dialysis prior to transplantation, mob | 49.4±42 | 57.8±46.2 | 48.8±41.8 | 0.09 |
| Multiorgan recipients, no. (%) | 96 (8) | 4 (6) | 92 (8) | 0.57 |
Plus-minus values are means ± SD.
a
P values are for the comparisons between COVID-19–positive and COVID-19–negative patients.
b
Time on dialysis prior to transplantation was available in 1078 patients.